Drugs / BERGAPTEN
BERGAPTEN
also known as
5-Methoxypsoralen · Bergaptan · Bergaptene · Geralen · Heraclin · Majudin · Methoxsalen related compound a · NSC-95437
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00533195 Comparator | Oct 2007 → Jan 2009 | atopic eczema | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BERGAPTEN | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | 5-Methoxypsoralen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00533195 ↗ |
| Known as | Bergaptan | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | Bergaptene | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | Geralen | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | Heraclin | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | Majudin | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | Methoxsalen related compound a | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Known as | NSC-95437 | ChEMBL registry synonym — accepted as the source's own label CHEMBL24171 ↗ |
| Modality | Small molecule | — CHEMBL24171 ↗ |
| Route | Oral | “1,2 mg/kg 2 hours before UVA irradiation p.o. 3 times weekly for 5 weeks” NCT00533195 ↗ |